We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

NYC Files Antitrust Suit Vs. Glaxo Over Paxil Patents

Law360 (May 19, 2004, 12:00 AM EDT) -- The City of New York has filed a lawsuit against U.K. drug maker GlaxoSmithKline PLC, claiming that the company engaged in "anticompetitive, fraudulent, and inequitable conduct" when it acquired patents for its anti-depressant Paxil.

The complaint claims seeks repayment of the millions of dollars the city has spent purchasing Paxil for New York residents through the Medicaid program.

The suit, filed in U.S. District Court in Philadelphia on Tuesday, alleges that Glaxo hept generic versions of the drug off the market by obtaining more than a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.